1.Isolation of meticillin-resistant Staphylococcus aureus sequence type 9 in pigs in Taiwan.Tsai HY, Liao CH, Cheng A, Liu CY, Huang YT, Teng LJ, Hsueh PR. Int J Antimicrob Agents. 2012 May;39(5):449-51.

2.Trends in susceptibility of vancomycin-resistant Enterococcus faecium to tigecycline, daptomycin, and linezolid and molecular epidemiology of the isolates: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006 to 2010.Tsai HY, Liao CH, Chen YH, Lu PL, Huang CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR. Antimicrob Agents Chemother. 2012 Jun;56(6):3402-5.

3.Emergence of tigecycline-resistant Klebsiella pneumoniae after tigecycline therapy for complicated urinary tract infection caused by carbapenem-resistant Escherichia coli.Tsai HY, Liao CH, Cheng A, Liu CY, Huang YT, Sheng WH, Hsueh PR. J Infect. 2012 Dec;65(6):584-6.

4.Streptococcus suis infection in Taiwan, 2000-2011.Tsai HY, Liao CH, Liu CY, Huang YT, Teng LJ, Hsueh PR. Diagn Microbiol Infect Dis. 2012 Sep;74(1):75-7.

5. Updated antibiotic resistance and clinical spectrum of infections caused by Streptococcus pneumoniae in Taiwan: Emphasis on risk factors for penicillin nonsusceptibilities.Tsai HY, Lauderdale TL, Wang JT, Chen YS, Liu JW, Huang JH, Hu BH, Yang CJ, Lu DC, Chang SC. J Microbiol Immunol Infect. 2013 Oct;46(5):345-51.

6.Cronobacter infections not from infant formula, Taiwan.Tsai HY, Liao CH, Huang YT, Lee PI, Hsueh PR. Emerg Infect Dis. 2013 Jan;19(1):167-9.

7.Trends in the antimicrobial susceptibilities and serotypes of Streptococcus pneumoniae: results from the Tigecycline In Vitro Surveillance in Taiwan (TIST) study, 2006-2010.Tsai HY, Chen YH, Liao CH, Lu PL, Huang CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR. Int J Antimicrob Agents. 2013 Oct;42(4):312-6.

8.Carbapenems and piperacillin/tazobactam for the treatment of bacteremia caused by extended-spectrum β-lactamase-producing Proteus mirabilis.Tsai HY, Chen YH, Tang HJ, Huang CC, Liao CH, Chu FY, Chuang YC, Sheng WH, Ko WC, Hsueh PR. Diagn Microbiol Infect Dis. 2014 Nov;80(3):222-6.  

9.In vitro synergy of penicillin, ceftriaxone and levofloxacin against serotype 19A Streptococcus pneumoniae.Tsai HY, Liao CH, Liu CY, Huang YT, Hsueh PR. Int J Antimicrob Agents. 2015 Dec;46(6):722-5.

（更新日期：2020年12月23日）